BR112014001539A2 - processo para obter uma composição contendo fatores de crescimento de um composto do sangue, e composição obtida pelo dito processo - Google Patents

processo para obter uma composição contendo fatores de crescimento de um composto do sangue, e composição obtida pelo dito processo

Info

Publication number
BR112014001539A2
BR112014001539A2 BR112014001539A BR112014001539A BR112014001539A2 BR 112014001539 A2 BR112014001539 A2 BR 112014001539A2 BR 112014001539 A BR112014001539 A BR 112014001539A BR 112014001539 A BR112014001539 A BR 112014001539A BR 112014001539 A2 BR112014001539 A2 BR 112014001539A2
Authority
BR
Brazil
Prior art keywords
obtaining
growth factors
containing growth
composition containing
composition
Prior art date
Application number
BR112014001539A
Other languages
English (en)
Inventor
Anitua Aldecoa Eduardo
Original Assignee
Anitua Aldecoa Eduardo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anitua Aldecoa Eduardo filed Critical Anitua Aldecoa Eduardo
Publication of BR112014001539A2 publication Critical patent/BR112014001539A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
BR112014001539A 2011-07-29 2012-07-13 processo para obter uma composição contendo fatores de crescimento de um composto do sangue, e composição obtida pelo dito processo BR112014001539A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES201100867A ES2369945B1 (es) 2011-07-29 2011-07-29 Procedimiento de obtención de una composición que contiene factores de crecimiento a partir de un compuesto sanguíneo, y composición obtenible por dicho procedimiento.
PCT/ES2012/000196 WO2013017707A1 (es) 2011-07-29 2012-07-13 Procedimiento de obtención de una composición que contiene factores de crecimiento a partir de plaquetas

Publications (1)

Publication Number Publication Date
BR112014001539A2 true BR112014001539A2 (pt) 2017-02-14

Family

ID=44996381

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014001539A BR112014001539A2 (pt) 2011-07-29 2012-07-13 processo para obter uma composição contendo fatores de crescimento de um composto do sangue, e composição obtida pelo dito processo

Country Status (16)

Country Link
US (1) US8993733B2 (pt)
EP (1) EP2740486A1 (pt)
JP (1) JP2014521629A (pt)
KR (1) KR20140057244A (pt)
CN (1) CN103702679B (pt)
AR (1) AR087374A1 (pt)
BR (1) BR112014001539A2 (pt)
CA (1) CA2839973A1 (pt)
CL (1) CL2014000163A1 (pt)
CO (1) CO6862109A2 (pt)
ES (1) ES2369945B1 (pt)
MX (1) MX2014000936A (pt)
PE (1) PE20141264A1 (pt)
RU (1) RU2014102729A (pt)
TW (1) TW201309310A (pt)
WO (1) WO2013017707A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2442242B1 (es) 2012-08-09 2014-11-25 Biotechnology Institute, I Mas D, S.L. Composición con factores de crecimiento destinada al tratamiento intranasal de una enfermedad neurodegenerativa u otra patología del sistema nervioso central, y su método de fabricación.
ES2527967B1 (es) * 2013-08-01 2015-12-28 Biotechnology Institute, I Mas D, S.L. Formulación de una composición sanguínea rica en plaquetas y/o factores de crecimiento, con proteínas gelificadas y método de preparación de la misma
HK1194912A2 (en) * 2013-09-17 2014-10-24 Bestop Group Holdings Ltd Growth factor concentrate and the use thereof
US10105306B2 (en) * 2013-09-17 2018-10-23 Bestop Group Holdings Limited Method of preparing a growth factor concentrate
CA2950659A1 (en) * 2016-12-06 2018-06-06 Antnor Limited Method for the preparation and prolonged storage of growth factors and cytokines obtained from platelet rich plasma
CA3078625C (en) 2017-10-09 2023-01-17 Terumo Bct Biotechnologies, Llc Lyophilization container and method of using same
JP6391872B1 (ja) * 2018-03-30 2018-09-19 セルソース株式会社 成長因子混合物およびその調製方法
ES2778798B2 (es) 2019-02-11 2021-10-13 Biotechnology Inst I Mas D Sl Formulacion o adhesivo tisular obtenida de una composicion sanguinea que contiene plaquetas, y metodo de preparacion de dicha formulacion
ES2782723B2 (es) * 2019-03-13 2021-05-18 Active Bioregeneration Tech Sl Procedimiento para obtencion y conservacion de factores de crecimiento de alta pureza y sus usos
CA3130668A1 (en) 2019-03-14 2020-12-03 Terumo Bct Biotechnologies, Llc Multi-part lyophilization container and method of use
EP3881858A1 (en) * 2020-03-20 2021-09-22 Rok Pangersic Heat-treated platelet-derived growth factor extract for use in a method of preventing or treating a tissue defect

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5871997A (en) * 1994-07-21 1999-02-16 Alexion Pharmaceuticals, Inc. Methods and compositions for protecting retroviral vector particles and producer cells from inactivation by complement via reduction of the expression or recognition of galactose alpha (1,3) galactosyl epitopes
AR022333A1 (es) 1999-01-26 2002-09-04 Anitua Aldecoa Eduardo Regenerador de tejido oseo
JP2004532277A (ja) * 2001-06-08 2004-10-21 パウダージェクト ワクチンズ，インコーポレーテッド 噴霧凍結乾燥組成物
US20030068416A1 (en) * 2001-09-24 2003-04-10 Wilson Burgess Method of lyophylization to reduce solvent content and enhance product recovery
ES2221770B2 (es) 2002-04-19 2006-07-16 Eduardo Anitua Aldecoa Metodo de preparacion de un compuesto para la regeneracion de tejidos.
US20060004189A1 (en) * 2004-07-02 2006-01-05 James Gandy Compositions for treating wounds and processes for their preparation
US20060142198A1 (en) * 2004-07-02 2006-06-29 Wound Care Partners Llc Compositions for treating wounds and processes for their preparation
US7931919B2 (en) * 2005-08-12 2011-04-26 The United States Of America As Represented By The Secretary Of The Army Method of producing glycine-stabilized, lyophilized plasma
JP2008109866A (ja) * 2006-10-30 2008-05-15 Jms Co Ltd 培地添加剤、この培地添加剤を含む培地、及びこの培地を用いた細胞の培養方法
WO2008078189A2 (en) * 2006-12-20 2008-07-03 Bayer Healthcare Llc Factor vii and viia compositions
KR101284154B1 (ko) * 2007-03-07 2013-07-10 가부시끼가이샤 제이엠에스 혈청조제방법 및 혈청조제장치
JP2009050297A (ja) * 2007-08-23 2009-03-12 Tokyo Medical & Dental Univ 脱細胞処理液、脱細胞化組織の調製方法、移植片、及び培養部材
EP2077118A1 (en) * 2008-01-07 2009-07-08 Gwo Rei Biomedical Technology Corp. Clottable concentrate of platelet growth factors and preparation method thereof
TR201100913T1 (tr) 2008-07-31 2011-06-21 Naval Cat Internacional S.A.S. Güçlendirilmiş plastik gemilerde yangın-sınırlayıcı düzenleme.
EP2430977B1 (en) 2009-05-14 2020-01-08 Biotechnology Institute, I Mas D, S.L. Method for preparing at least one compound from blood, and sampling device for use when carrying out said method
EP2442798A4 (en) * 2009-06-18 2013-03-13 Wyeth Llc LYOPHILIZED FORMULATIONS FOR SMALL-SCALE MODULAR IMMUNOPHARMACEUTICAL AGENTS
JP2013039036A (ja) * 2009-12-16 2013-02-28 Kyowa Hakko Kirin Co Ltd ＨＩＦ−２αの発現を抑制する核酸

Also Published As

Publication number Publication date
CL2014000163A1 (es) 2014-08-01
ES2369945A1 (es) 2011-12-09
WO2013017707A1 (es) 2013-02-07
US20130030161A1 (en) 2013-01-31
CN103702679A (zh) 2014-04-02
ES2369945B1 (es) 2012-10-15
PE20141264A1 (es) 2014-10-09
CA2839973A1 (en) 2013-02-07
CO6862109A2 (es) 2014-02-10
US8993733B2 (en) 2015-03-31
RU2014102729A (ru) 2015-09-10
EP2740486A1 (en) 2014-06-11
CN103702679B (zh) 2016-06-01
MX2014000936A (es) 2014-04-30
TW201309310A (zh) 2013-03-01
JP2014521629A (ja) 2014-08-28
AR087374A1 (es) 2014-03-19
KR20140057244A (ko) 2014-05-12

Similar Documents

Publication Publication Date Title
BR112014001539A2 (pt) processo para obter uma composição contendo fatores de crescimento de um composto do sangue, e composição obtida pelo dito processo
SMT201600274B (it) Processo per la preparazione di composti utili come inibitori del sglt2
BR112014010460A2 (pt) composto, composição farmacêutica, processo para produzir uma composição farmacêutica, método de tratamento, kit e uso de uma composição farmacêutica
BR112014010197A2 (pt) composto, composição farmacêutica, método de tratamento de um distúrbio
BR112014008196A2 (pt) processo para a preparação de um composto
BR112014010391A2 (pt) composto, composição farmacêutica, processo de produção de uma composição farmacêutica, método de tratamento, kit e uso de uma composição farmacêutica
BR112014003220A2 (pt) composto de fórmula (i), processo para preparar um composto de fórmula i e v, uso do composto de fórmula i, método para controlar uma praga invertebrada, forma cristalina, uso das formas cristalinas e método para controlar uma praga invertebrada
BR112013032008A2 (pt) composição de uma composição nutricional; produto obtido pelo processo
BR112014011672A2 (pt) processo para preparar ácido levulínico
BR112014012414A2 (pt) processo para a preparação de 5-flúor-1h-pirazolopiridinas substituídas
BR112013019520A2 (pt) método para produção de 2,3-butanodiol por fermentação
BR112013022277A2 (pt) método para produção de cadeia de açúcar contendo ácido siálico
BR112013030833A2 (pt) processo para a preparação de um composto de formula (i) e processo para a preparação de estetrol
BR112014014232A2 (pt) composto e método para a preparação de um composto
BR112013008497A2 (pt) peça de suporte de um composto de colmeia, bem como processo para o seu revestimento
BR112014013213A2 (pt) composição microbicida, método para fornecer um efeito bactericida a um substrato e uso de uma composição
BR112014013354A2 (pt) processo para a preparação de um polímero, composição, composto, e, formulação
BR112013023465A2 (pt) método para produzir l-cisteína
BR112014010997A2 (pt) processo para o preparo de ß-glicosídeos de c-arila
BR112013012873A2 (pt) processo para preparar uma n, n-dialquiletanolamina
BR112013016073A2 (pt) método para produçao de compostos orgânicos
BR112014009775A2 (pt) composição, método, semente e composto de fórmula 1
BR112014011620A2 (pt) processo de preparação de pelo menos uma nitrila
BR112014000397A2 (pt) processo para a preparação de pelo menos uma nitrila
BR112014015512A2 (pt) processo para a preparação de um composto

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2470 DE 08-05-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.